Table 4. Overall analysis of ICOS rs4404254 T>C, rs10932029 T>C, CD28 rs3116496 T>C and CD80 rs7628626 C>A polymorphisms with HCC.
Genotype | Overall (584 cases vs. 923 controls) | |||
---|---|---|---|---|
Crude OR (95% CI) | P | Adjusted OR1 (95% CI) | P | |
ICOS rs10932029 T>C | ||||
Additive model | 1.64 (1.27–2.12) | <0.001 | 1.59 (1.13–2.22) | 0.007 |
Homozygote model | 1.99 (0.76–5.19) | 0.161 | 1.12 (0.31–4.03) | 0.867 |
Dominant model | 1.69 (1.32–2.17) | <0.001 | 1.58 (1.14–2.19) | 0.007 |
Recessive model | 1.82 (0.76–4.73) | 0.223 | 1.02 (0.28–3.68) | 0.974 |
ICOS rs4404254 T>C | ||||
Additive model | 1.13 (0.90–1.42) | 0.299 | 0.94 (0.69–1.28) | 0.698 |
Homozygote model | 1.13 (0.63–2.03) | 0.675 | 1.21 (0.56–2.61) | 0.636 |
Dominant model | 1.15 (0.92–1.44) | 0.210 | 0.98 (0.73–1.31) | 0.884 |
Recessive model | 1.11 (0.62–1.98) | 0.728 | 1.24 (0.58–2.66) | 0.587 |
CD28 rs3116496 T>C | ||||
Additive model | 0.97 (0.74–1.28) | 0.821 | 0.87 (0.60–1.25) | 0.437 |
Homozygote model | 1.98 (0.78–5.06) | 0.153 | 1.54 (0.44–5.44) | 0.503 |
Dominant model | 1.03 (0.79–1.35) | 0.809 | 0.91 (0.64–1.29) | 0.594 |
Recessive model | 2.02 (0.79–5.15) | 0.141 | 1.59 (0.45–5.61) | 0.468 |
CD80 rs7628626 C>A | ||||
Additive model | 1.02 (0.79–1.32) | 0.901 | 1.00 (0.71–1.40) | 0.998 |
Homozygote model | 1.33 (0.57–3.10) | 0.513 | 1.72 (0.57–5.19) | 0.332 |
Dominant model | 1.05 (0.82–-1.35) | 0.684 | 1.05 (0.76–1.46) | 0.777 |
Recessive model | 1.34 (0.58–3.12) | 0.497 | 1.73 (0.58–5.20) | 0.326 |
Adjusted for age, sex, chronic HBV infection, smoking and alcohol use in a logistic regression model.